Tronox Holdings plc
TROX NYSE Industrial Inorganic Chemicals Financials FY2016–FY2025
Last close · Oct 23, 2026
$3.46
0.6%What Tronox Holdings plc does
No business description yet.
- Legal name
- Tronox Holdings plc
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 20, 2026
- Accession · CIK
- 0001530804-26-000006
0001530804
Revenue and margins
Tronox Holdings plc had $2.9B of revenue in fiscal 2025, down 5.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$281M in fiscal 2025, −9.7% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Tronox Holdings plc returned $48.0M to shareholders in fiscal 2025. The diluted share count rose 0.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Tronox Holdings plc can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $228M | $164M | $273M | $151M | $199M |
| Debt incl. finance leases | $2.6B | $2.6B | $2.9B | $2.9B | $3.3B |
| Net debt / EBITDA | 2.7x | 3.3x | 5.6x | 5.5x | 62.5x |
| Debt / equity | 1.3x | 1.1x | 1.5x | 1.6x | 2.3x |
| Interest coverage | 3.7x | 3.7x | 1.2x | 1.3x | −1.3x |
| Current ratio | 2.5x | 2.3x | 2.8x | 2.5x | 2.5x |
| Quick ratio | 1.2x | 0.8x | 0.9x | 0.7x | 0.7x |
| Total assets | $6.0B | $6.3B | $6.1B | $6.0B | $6.2B |
| Total liabilities | $3.9B | $3.9B | $4.2B | $4.2B | $4.8B |
| Shareholders' equity | $2.0B | $2.4B | $1.9B | $1.8B | $1.4B |
| Net debt (− = net cash) | $2.4B | $2.4B | $2.6B | $2.8B | $3.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ |
| Current ratio rose | — | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ | ✕ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ |
| Gross margin rose | — | ✓ | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ | ✕ |
| Revenue rose relative to assets | — | ✓ | ✓ | ✓ | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ |
| F-score | — / 3 | 5 / 9 | 6 / 9 | 4 / 9 | 6 / 9 | 6 / 9 | 6 / 9 | 4 / 9 | 5 / 9 | 2 / 9 |
| Accruals ratio | −2.9% | −9.2% | −3.7% | −10.5% | 10.4% | −7.2% | −1.6% | −8.0% | −5.7% | −8.6% |
| Altman Z'' | 3.07 | 3.28 | 3.40 | 1.70 | 2.59 | 2.88 | 2.84 | 2.53 | 2.37 | 1.47 |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.3B | $1.7B | $1.8B | $2.6B | $2.8B | $3.6B | $3.5B | $2.9B | $3.1B | $2.9B |
| Net interest income | $3.0M | $10.0M | — | — | — | — | — | — | — | — |
| Gross profit | $133M | $389M | $498M | $464M | $621M | $895M | $832M | $462M | $515M | $269M |
| Research and development | $9.0M | $8.0M | $11.0M | $17.0M | $12.0M | $13.0M | $12.0M | $12.0M | $14.0M | $15.0M |
| Operating income | −$53.0M | $141M | $200M | $95.0M | $271M | $577M | $458M | $186M | $219M | −$253M |
| Interest expense | $185M | $188M | $193M | $201M | $189M | $157M | $125M | $158M | $167M | $189M |
| Pretax income | −$264M | −$87.0M | $43.0M | −$88.0M | $114M | $374M | $308M | $49.0M | $73.0M | −$458M |
| Income tax | −$125M | $6.0M | $13.0M | $14.0M | −$881M | $71.0M | −$192M | $363M | $127M | $15.0M |
| Net income | −$61.0M | −$285M | −$7.0M | −$109M | $969M | $286M | $497M | −$316M | −$48.0M | −$470M |
| Net income to common | −$61.0M | −$285M | −$7.0M | −$109M | $969M | $286M | $497M | −$316M | −$48.0M | −$470M |
| Diluted EPS | −$0.52 | −$2.39 | −$0.06 | −$0.78 | $6.69 | $1.81 | $3.16 | −$2.02 | −$0.31 | −$2.97 |
| Diluted shares | 0.12B | 0.12B | 0.12B | 0.14B | 0.14B | 0.16B | 0.16B | 0.16B | 0.16B | 0.16B |
| Cash flow | ||||||||||
| Cash from operations | $84.0M | $165M | $170M | $412M | $355M | $740M | $598M | $184M | $300M | $60.0M |
| Capital expenditure | $86.0M | $91.0M | $117M | $198M | $195M | $272M | $428M | $261M | $370M | $341M |
| Free cash flow | −$2.0M | $74.0M | $53.0M | $214M | $160M | $468M | $170M | −$77.0M | −$70.0M | −$281M |
| Depreciation and amortization | $177M | $182M | $195M | $280M | $304M | $297M | $269M | $275M | $285M | $302M |
| Stock-based compensation | $24.0M | $31.0M | $21.0M | $32.0M | −$4.0M | $3.0M | $26.0M | $4.0M | $21.0M | $20.0M |
| Acquisitions | $0.0M | $0.0M | — | — | — | — | — | — | — | — |
| Share buybacks | — | $0.0M | $0.0M | $288M | $0.0M | $0.0M | $50.0M | $0.0M | $0.0M | — |
| Dividends paid | $46.0M | $23.0M | $23.0M | $27.0M | $40.0M | $65.0M | $87.0M | $89.0M | $80.0M | $48.0M |
| Dividends and buybacks | $46.0M | $23.0M | $23.0M | $315M | $40.0M | $65.0M | $137M | $89.0M | $80.0M | $48.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $248M | $1.1B | $1.0B | $302M | $619M | $228M | $164M | $273M | $151M | $199M |
| Total debt | $3.1B | $3.1B | $3.1B | $3.0B | $3.3B | $2.6B | $2.5B | $2.8B | $2.9B | $3.2B |
| Finance lease liabilities | — | — | — | $15.0M | $15.0M | $14.0M | $47.0M | $43.0M | $42.0M | $39.0M |
| Current assets | $2.7B | $2.6B | $2.5B | $2.1B | $2.5B | $2.0B | $2.0B | $2.1B | $2.2B | $2.3B |
| Current liabilities | $564M | $353M | $300M | $702M | $805M | $822M | $850M | $753M | $874M | $919M |
| Inventory | $499M | $473M | $479M | $1.1B | $1.1B | $1.0B | $1.3B | $1.4B | $1.6B | $1.7B |
| Property and equipment, net | $1.1B | $1.1B | $1.0B | $1.8B | $1.8B | $1.7B | $1.8B | $1.8B | $1.9B | $2.0B |
| Goodwill | — | — | $0.0M | — | — | — | — | — | — | — |
| Intangible assets | $223M | $198M | $176M | $208M | $201M | $217M | $250M | $243M | $244M | $214M |
| Total assets | $5.0B | $4.9B | $4.6B | $5.3B | $6.6B | $6.0B | $6.3B | $6.1B | $6.0B | $6.2B |
| Total liabilities | $3.8B | $3.8B | $3.8B | $4.4B | $4.7B | $3.9B | $3.9B | $4.2B | $4.2B | $4.8B |
| Shareholders' equity | $1.0B | $829M | $683M | $748M | $1.7B | $2.0B | $2.4B | $1.9B | $1.8B | $1.4B |
| Margins | ||||||||||
| Gross margin | 10.2% | 22.9% | 27.4% | 17.6% | 22.5% | 25.1% | 24.1% | 16.2% | 16.8% | 9.3% |
| Operating margin | −4.0% | 8.3% | 11.0% | 3.6% | 9.8% | 16.2% | 13.3% | 6.5% | 7.1% | −8.7% |
| EBITDA margin | 9.5% | 19.0% | 21.7% | 14.2% | 20.8% | 24.5% | 21.0% | 16.2% | 16.4% | 1.7% |
| Net margin | −4.7% | −16.8% | −0.4% | −4.1% | 35.1% | 8.0% | 14.4% | −11.1% | −1.6% | −16.2% |
| FCF margin | −0.2% | 4.4% | 2.9% | 8.1% | 5.8% | 13.1% | 4.9% | −2.7% | −2.3% | −9.7% |
| Net interest share of revenue | 0.2% | 0.6% | — | — | — | — | — | — | — | — |
| Returns | ||||||||||
| Return on capital | −1.1% | 3.9% | 5.0% | 2.2% | 6.2% | 10.8% | 9.7% | 2.7% | 3.2% | −4.5% |
| Return on capital employed | −1.2% | 3.1% | 4.6% | 2.1% | 4.7% | 11.2% | 8.4% | 3.5% | 4.2% | −4.8% |
| Return on equity | −6.0% | −31.0% | −0.9% | −15.2% | 79.2% | 15.5% | 22.8% | −14.7% | −2.6% | −29.6% |
| Return on assets | −1.2% | −5.8% | −0.1% | −2.2% | 16.4% | 4.6% | 8.1% | −5.1% | −0.8% | −7.7% |
| Return on tangible equity | −7.8% | −45.2% | −1.4% | −20.2% | 64.7% | 16.1% | 23.6% | −18.7% | −3.2% | −39.0% |
| Growth | ||||||||||
| Revenue growth | — | 29.7% | 7.1% | 45.2% | 4.4% | 29.5% | −3.3% | −17.5% | 7.9% | −5.7% |
| Net income growth | — | — | — | — | — | −70.5% | 73.8% | −163.6% | — | — |
| EPS growth | — | — | — | — | — | −72.9% | 74.6% | −163.9% | — | — |
| FCF growth | — | — | −28.4% | 303.8% | −25.2% | 192.5% | −63.7% | −145.3% | — | — |
| Share count change | — | 2.9% | 2.8% | 13.8% | 3.6% | 9.0% | −0.5% | −0.5% | 0.9% | 0.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 22.9x | 6.2x | 5.3x | 7.3x | 4.7x | 2.7x | 3.3x | 5.6x | 5.5x | 62.5x |
| Debt / equity | 3.1x | 3.8x | 4.6x | 4.0x | 2.0x | 1.3x | 1.1x | 1.5x | 1.6x | 2.3x |
| Interest coverage | −0.3x | 0.8x | 1.0x | 0.5x | 1.4x | 3.7x | 3.7x | 1.2x | 1.3x | −1.3x |
| Current ratio | 4.9x | 7.5x | 8.5x | 3.0x | 3.1x | 2.5x | 2.3x | 2.8x | 2.5x | 2.5x |
| Quick ratio | 4.0x | 6.1x | 6.9x | 1.3x | 1.7x | 1.2x | 0.8x | 0.9x | 0.7x | 0.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.6% | 5.4% | 6.4% | 7.5% | 7.1% | 7.6% | 12.4% | 9.2% | 12.0% | 11.8% |
| Stock comp / revenue | 1.8% | 1.8% | 1.2% | 1.2% | −0.1% | 0.1% | 0.8% | 0.1% | 0.7% | 0.7% |
| Payouts / FCF | — | 31.1% | 43.4% | 147.2% | 25.0% | 13.9% | 80.6% | — | — | — |
| Quality scores | ||||||||||
| Piotroski F-score | — | 5.0 | 6.0 | 4.0 | 6.0 | 6.0 | 6.0 | 4.0 | 5.0 | 2.0 |
| Altman Z'' | 3.1 | 3.3 | 3.4 | 1.7 | 2.6 | 2.9 | 2.8 | 2.5 | 2.4 | 1.5 |
| Accruals ratio | −2.9% | −9.2% | −3.7% | −10.5% | 10.4% | −7.2% | −1.6% | −8.0% | −5.7% | −8.6% |
Source: SEC EDGAR XBRL filings (CIK 0001530804). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
